Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Goodwill E-Health Info Co., Ltd. (688246.SS)
Beijing, GD, CN
Goodwill E-Health Info Co., Ltd. engages in the research and development of medical information software in China. The company offers comprehensive electronic medical records, specialist electronic medical records, hospital data centers, smart medical product systems, internet medical product systems, hospital evaluation solutions, county medical community solutions, medical research solutions, cloud HIS platform, and smart elderly care solutions. It also provides IT strategic planning, management consulting, information system design, application software development, and operation and maintenance value-added services. The company was founded in 2006 and is based in Beijing, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.24% | +2.16% | +23.82% | -6.89% | -5.63% | +1.72% | -23.69% | -42.27% | -44.68% | -44.68% | -44.68% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Distribution: +5.6%-32.2% Q1'26: -16.2% (vs Q1'25)
-
EPS growth Medical - Distribution: +4.9%+2.2% Q1'26: +23.1% (vs Q1'25)
-
FCF margin FCF growth · Medical - Distribution: +37.6%-51.8% Q1'26: -79.7% (vs Q1'25)
-
EBIT margin Medical - Distribution: +3.0%-71.5% Q1'26: -24.9% (vs Q1'25)
-
ROIC Medical - Distribution: +5.7%-20.7% Q1'26: -5.5% (vs Q1'25)
-
Share dilution Medical - Distribution: +0.0%-0.2% ★ Q1'26: +2.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Distribution: 0.87×-1.32× Q1'26: -3.05× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
531.84M
est: 646.89M (-17.8%)
|
651.94M
est: 646.89M (+0.8%)
|
716.95M
est: 780.00M (-8.1%)
|
695.18M
est: 703.70M (-1.2%)
|
591.94M
est: 778.60M (-24.0%)
|
401.33M
est: 529.00M (-24.1%)
|
491.87M
439.61M – 544.13M
-7.0% YoY
|
600.32M
493.57M – 707.07M
+22.0% YoY
|
734.64M
656.58M – 812.70M
+22.4% YoY
|
| EBITDA |
16.09M
est: -15.05M (+206.9%)
|
36.29M
est: -15.05M (+341.1%)
|
32.69M
est: -18.15M (+280.1%)
|
6.05M
est: -137.75M (+104.4%)
|
-216.22M
est: -152.42M (-41.9%)
|
-234.55M
est: -103.55M (-126.5%)
|
-96.29M
-106.52M – -86.06M
+7.0% YoY
|
-117.52M
-138.41M – -96.62M
-22.0% YoY
|
-143.81M
-159.09M – -128.53M
-22.4% YoY
|
| EBIT |
12.61M
est: -31.40M (+140.2%)
|
32.83M
est: -31.40M (+204.5%)
|
29.05M
est: -37.86M (+176.7%)
|
-1.93M
est: -142.69M (+98.7%)
|
-219.42M
est: -157.88M (-39.0%)
|
-286.97M
est: -107.27M (-167.5%)
|
-99.74M
-110.34M – -89.14M
+7.0% YoY
|
-121.73M
-143.38M – -100.09M
-22.0% YoY
|
-148.97M
-164.80M – -133.14M
-22.4% YoY
|
| Net Income |
21.27M
est: 48.16M (-55.8%)
|
49.61M
est: 48.16M (+3.0%)
|
68.02M
est: 66.04M (+3.0%)
|
32.28M
est: 38.19M (-15.5%)
|
-256.12M
est: 81.05M (-416.0%)
|
-250.49M
est: -147.00M (-70.4%)
|
-81.45M
-92.25M – -69.86M
+44.6% YoY
|
8.24M
1.05M – 15.43M
+110.1% YoY
|
65.32M
55.65M – 73.49M
+692.5% YoY
|
| SGA |
142.75M
est: 109.48M (+30.4%)
|
165.02M
est: 109.48M (+50.7%)
|
175.63M
est: 132.01M (+33.0%)
|
182.40M
est: 147.33M (+23.8%)
|
169.53M
est: 163.02M (+4.0%)
|
51.40M
est: 110.76M (-53.6%)
|
102.98M
92.04M – 113.93M
-7.0% YoY
|
125.69M
103.34M – 148.04M
+22.0% YoY
|
153.81M
137.47M – 170.16M
+22.4% YoY
|
| EPS |
0.21
est: 0.35 (-40.0%)
|
0.48
est: 0.35 (+37.1%)
|
0.49
est: 0.48 (+2.1%)
|
0.23
est: 0.28 (-17.1%)
|
-1.86
est: 0.59 (-415.3%)
|
-1.82
est: -1.07 (-70.1%)
|
-0.59
-0.67 – -0.51
+44.9% YoY
|
0.06
0.01 – 0.11
+110.2% YoY
|
0.47
0.41 – 0.53
+683.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jing Li | Board Secretary & Deputy GM | — | female |
| Jun Xia | Chairman & GM | — | male |
| Yalun Nie | Deputy General Manager | — | male |
| Ying Liu | Accounting Supervisor | — | — |
| Yong Ren | Chief Financial Officer, Deputy GM & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 688246.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
